Laurence Lytton and Foundation Hold 9.99% in IN8BIO (NASDAQ: INAB)
Rhea-AI Filing Summary
IN8BIO, Inc. reports that Laurence W. Lytton and the Lytton-Kambara Foundation each beneficially own 9.99% of Common Stock, consisting of 984,031 shares reported for each holder.
The filing states that the reported holdings "consist of 900,000 shares of Common Stock and warrants to purchase 1,092,753 shares of Common Stock, subject to a 9.99% beneficial ownership limitation," and that the percentage was calculated based on 9,766,132 shares outstanding as of January 12, 2026, per a prospectus dated January 28, 2026.
Positive
- None.
Negative
- None.
Insights
Holders report large, capped stakes via shared power and warrants.
The filing shows shared voting and dispositive power of 984,031 shares for both Laurence W. Lytton and the Lytton-Kambara Foundation, each equal to 9.99% of the class as calculated on January 12, 2026.
Reported holdings "consist of 900,000 shares and warrants to purchase 1,092,753 shares," with a beneficial ownership limitation of 9.99%. Timing and exercise mechanics for the warrants are not detailed in the excerpt; subsequent filings may clarify potential conversion timing and dilution.